MedTrace Logo

Myeloid Cells in Aortic Valve Stenosis

NCT04717219 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2022-04-12

No results posted yet for this study

Summary

Investigators plan to characterize systemic inflammation and circulating immune cells in participants with moderate and severe calcific aortic valve disease and matched healthy controls.

Conditions

  • Aortic Valve Disease
  • Aortic Valve Stenosis

Interventions

OTHER

Blood drawing

Blood will be drawn after inclusion of the participants.

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Niels P. Riksen, prof. dr. · Radboud University Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-19
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04717219 on ClinicalTrials.gov